Literature DB >> 11474484

Decreased activities of lipoprotein lipase and hepatic triglyceride lipase in patients with gout.

Z Tsutsumi1, T Yamamoto, Y Moriwaki, S Takahashi, T Hada.   

Abstract

Postheparin plasma lipoprotein lipase (LPL) and hepatic triglyceride lipase (HTGL) activities were measured in 30 male primary gout patients as well as in control subjects. The activities of these lipolytic enzymes were significantly decreased in the patients as compared with the controls (gout v control; LPL, 5.4 +/- 0.4 v 7.9 +/- 0.9 U; HTGL, 14.6 +/- 2.0 v 17.9 +/- 3.4 U) when matched with serum triglyceride concentration. Further, LPL activity was negatively correlated with serum- and very-low-density lipoprotein (VLDL)-triglyceride in gout patients, while that of HTGL was negatively correlated with low-density lipoprotein (LDL)-triglyceride in both gout patients and control subjects. These results suggest that decreased activities of LPL and HTGL may contribute, in part, to the increased concentrations of serum-, VLDL-, and LDL-triglyceride seen in gout patients, leading to a higher risk for coronary atherosclerotic diseases in gout. Copyright 2001 by W.B. Saunders Company

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11474484     DOI: 10.1053/meta.2001.24930

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  3 in total

1.  The relationship of apolipoprotein B and very low density lipoprotein triglyceride with hyperuricemia and gout.

Authors:  Humaira Rasheed; Angela Hsu; Nicola Dalbeth; Lisa K Stamp; Sally McCormick; Tony R Merriman
Journal:  Arthritis Res Ther       Date:  2014-11-29       Impact factor: 5.156

2.  The cross-sectional study of hepatic lipase SNPs and plasma lipid levels.

Authors:  Wang Wei; Tian Hu; Huilong Luo; Zhang Ye; Feiteng Lu; Yanqing Wu; Muying Ying
Journal:  Food Sci Nutr       Date:  2020-01-13       Impact factor: 2.863

3.  The efficacy and tolerability of febuxostat treatment in a cohort of Chinese Han population with history of gout.

Authors:  Yuan-Yuan Huang; Zhuang Ye; San-Wei Gu; Zhen-Yu Jiang; Ling Zhao
Journal:  J Int Med Res       Date:  2020-05       Impact factor: 1.671

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.